Skip to main content
Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc. — Investor Relations & Filings

Ticker · ACRS ISIN · US00461U1051 LEI · 5493000B2LQ9QTW1DF52 US Manufacturing
Open in API
Filings indexed 844 across all filing types
Latest filing 2024-07-31 Director's Dealing
Country US United States of America
Listing US ACRS

About Aclaris Therapeutics, Inc.

https://www.aclaristx.com/

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel drug candidates for immuno-inflammatory diseases. The company leverages its core expertise in drug discovery, development, and kinase inhibition to create a pipeline of both small and large molecule drugs. Aclaris focuses on translating scientific discovery into innovative therapies to address the needs of patients with underserved conditions.

Recent filings

Filing Released Lang Actions
Director's Dealing 2024
Director's Dealing
2024-07-31 English
Director's Dealing 2024
Director's Dealing
2024-07-22 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement involving a royalty purchase agreement. It includes details about the transaction, payment terms, and references to future filings (Form 10-Q). There are no financial statements or detailed financial analysis included, only a description of the agreement and a press release. This type of filing is best classified as a Capital/Financing Update (CAP) because it relates to a financing transaction involving the sale of future royalty payments. It is not an Annual Report, Earnings Release, or Management Report, nor is it a Regulatory Filing fallback since the content is specific to a financing event. The document length and detail support this classification with high confidence.
2024-07-16 English
Major Shareholding Notification 2024
Major Shareholding Notification
2024-07-08 English
Director's Dealing 2024
Director's Dealing
2024-07-05 English
Director's Dealing 2024
Director's Dealing
2024-07-03 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.